Quantcast
  • HEALTH NEWS
    • HEALTH BREAKTHROUGHS
    • LAW AND POLITICS
    • HEALTHY AGING
    • HUNTING
    • MONEY
  • HEALTH CONDITIONS
    • BALANCE
    • BONE HEALTH
    • BRAIN HEALTH
    • BREATHING
    • CANCER
    • COLD & FLU
    • COVID-19
    • DIABETES
    • DIGESTIVE HEALTH
    • HEARING
    • HEART HEALTH
    • HIGH BLOOD PRESSURE
    • MEN’S HEALTH
    • WOMEN’S HEALTH
    • PAIN
  • SELF CARE
    • BEAUTY
    • DIET AND NUTRITION
    • FITNESS
    • HOME REMEDIES
    • SLEEP
    • TRAVEL & ENTERTAINMENT
  • MOST READ
  • CELEBRITY HEALTH
  • MORE
    • MIND HEALTH
      • ALZHEIMER’S DISEASE/DEMENTIA
      • EMOTIONS
      • FAITH
      • RELATIONSHIPS
    • MEDICINE AND RX
    • WEIRD HEALTH (READER DISCRETION)
    • PET & ANIMAL HEALTH
Search
Logo
Facebook
Twitter
Logo
  • HEALTH NEWS
    • HEALTH BREAKTHROUGHS
    • LAW AND POLITICS
    • HEALTHY AGING
    • HUNTING
    • MONEY
  • HEALTH CONDITIONS
    • BALANCE
    • BONE HEALTH
    • BRAIN HEALTH
    • BREATHING
    • CANCER
    • COLD & FLU
    • COVID-19
    • DIABETES
    • DIGESTIVE HEALTH
    • HEARING
    • HEART HEALTH
    • HIGH BLOOD PRESSURE
    • MEN’S HEALTH
    • WOMEN’S HEALTH
    • PAIN
  • SELF CARE
    • BEAUTY
    • DIET AND NUTRITION
    • FITNESS
    • HOME REMEDIES
    • SLEEP
    • TRAVEL & ENTERTAINMENT
  • MOST READ
  • CELEBRITY HEALTH
  • MORE
    • MIND HEALTH
      • ALZHEIMER’S DISEASE/DEMENTIA
      • EMOTIONS
      • FAITH
      • RELATIONSHIPS
    • MEDICINE AND RX
    • WEIRD HEALTH (READER DISCRETION)
    • PET & ANIMAL HEALTH

US officials made lucrative stock trades while preparing for Covid-19, WSJ reports

October 22, 2022
Hugh Auchincloss | Screenshot: CSPAN
Hugh Auchincloss | Screenshot: CSPAN

The principal deputy director at the NIH’s National Institute of Allergy and Infectious Diseases and one of Anthony Fauci’s top deputies made a six-figure stock market move while simultaneously managing US pandemic response, the Wall Street Journal has reported ...

CNN Business – Dozens of federal officials made lucrative stock and mutual fund trades in early 2020 as the government was preparing for the onslaught of Covid-19, according to a Wall Street Journal investigation.

In January of that year, while the public was broadly unaware of the scale and severity of the threat posed by the virus, US government agencies were mobilizing for a public health nightmare.

Many of the officials behind those efforts also made well-timed trades in industries that stood to gain or lose mightily from the pandemic, according to the report.

“Nearly 400 officials across 50 agencies reported owning stocks in airline, resort, hotel, restaurant and cruise companies in early 2020,” the Journal wrote.

It also cited roughly 240 officials who owned between $9 million and $28 million in stocks of drug, manufacturing and biotech firms that eventually won federal contracts related to Covid-19.

Trading spikes as government girds for crisis

...article continued below
- Advertisement -

The WSJ report was based on financial disclosure forms for roughly 12,000 government officials between 2016 and 2021. CNN has not independently verified the reporting.

In that crucial month of pandemic preparations, officials at the Department of Health and Human Services made far more stock sales than they had in previous months, the Journal reported. Their trading activity was 60% higher in January 2020 compared to the monthly average in 2019.

Federal officials are barred from working on matters in which they have a personal financial stake, and they’re not allowed to trade on nonpublic information acquired at work. They must disclose their financial assets and transactions every year.

The Journal said most agencies’ ethics rules focus on the kinds of stocks officials can trade, rather than when they can trade.

In one instance highlighted by the Journal, a high-ranking official at the National Institutes of Health reported selling $15,001 to $50,000 of a stock mutual fund on January 24 — the same day he sent an email describing the state of his department as “new coronavirus all the time.”

...article continued below
- Advertisement -

That official, Hugh Auchincloss, the principal deputy director at the NIH’s National Institute of Allergy and Infectious Diseases and one of Anthony Fauci’s top deputies, didn’t stop there …

READ MORE. 

SourceBy Allison Morrow, October 21, 2022
Click Here To Comment
Facebook
Twitter
ReddIt
Pinterest
Email
    - Advertisement -
    Previous article
    Herchel Walker Criticized by NY Times for Mental Illness, Brain-Damaged Fetterman Gets A Free Pass
    Next article
    Cholera 101: Why this ancient disease is making headlines in 2022
    - Advertisement -
    - Advertisement -

    TRENDING

    Fresh Produce Is an Increasingly Popular Prescription for Chronically Ill Patients

    KAISER HEALTH NEWS – When Mackenzie Sachs, a registered dietitian on the Blackfeet Reservation, in northwestern Montana, sees a patient experiencing high blood pressure,...

    USDA is thinking of Paraguay for fresh beef imports

    Consumer Health: What do you know about cornea transplantation?

    Ex-Clinton Official Did NOT Die from Turbulence

    E coli from meat behind half a million UTIs in the US every year, study suggests

    McDonald’s cancelled this popular item, so Wendy’s began serving it

    Star Wars actor dies age 56

    Iowa State Bans White Women from Retreat

    Woke Wisc. Prof. Decides She Identifies as Disabled

    Fetus Removed From Brain of 1-Year-Old Girl

    - Advertisement -
    - Advertisement -
    - Advertisement -

    RESOURCES
    Subscribe to Headline Health
    Not Receiving Our Emails?
    Unsubscribe/Update Email
    Privacy Policy
    Comment Policy
    Terms of Service
    Material Connection Disclosure
    RSS
    Accessibility

    CONTACT US
    Advertise with Headline Health
    Contact Us
    Digital Millennium Copyright Act (DMCA)

    HEADLINE HEALTH • PO BOX 49043 • CHARLOTTE, NC 28277

    THE INFORMATION PRESENTED HERE IS FOR GENERAL EDUCATIONAL PURPOSES ONLY. YOU SHOULD ALWAYS CONSULT WITH YOUR PERSONAL PHYSICIAN REGARDING ANY PERSONAL HEALTH PROBLEM, AND YOU SHOULD ALWAYS CONSULT WITH YOUR FINANCIAL ADVISER REGARDING INVESTMENT DECISIONS. FDA DISCLOSURE: THE STATEMENTS, ARTICLES, AND PRODUCTS FEATURED IN HEADLINE HEALTH EMAILS AND AT HEADLINEHEALTH.COM HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. NO INFORMATION OR PRODUCTS APPEARING IN EMAILS OR THE WEBSITE ARE INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE. MATERIAL CONNECTION DISCLOSURE: HEADLINE HEALTH MAY HAVE AN AFFILIATE RELATIONSHIP AND/OR ANOTHER MATERIAL CONNECTION TO ANY PERSONS OR BUSINESSES MENTIONED IN OR LINKED TO FROM EMAILS OR THE WEBSITE AND MAY RECEIVE COMMISSIONS FROM PURCHASES YOU MAKE ON SUBSEQUENT WEB SITES. YOU SHOULD NOT RELY SOLELY ON INFORMATION PUBLISHED BY HEADLINE HEALTH TO EVALUATE THE PRODUCT OR SERVICE BEING OFFERED. ALWAYS EXERCISE YOUR OWN DUE DILIGENCE BEFORE PURCHASING ANY PRODUCT OR SERVICE.

    Copyright 2023 HEADLINEHEALTH.COM